Targeted agent shows promise for chronic lymphoid leukemia
Monday, September 13, 2010 - 16:21
in Health & Medicine
Researchers at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) have identified an experimental agent that targets chronic lymphocytic leukemia and perhaps other proliferative disorders of lymphocytes.